The association between clinical prognostic factors and epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) efficacy in advanced non-small-cell lung cancer patients: a retrospective assessment of 94 cases with EGFR mutations

OBJECTIVE: This study aimed to examine the association of clinical prognostic factors with epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) efficacy in advanced non-small-cell lung cancer (NSCLC) patients. METHODS: The demographic and clinical characteristics of 94 patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Jing-Hui, Lin, Dong, Xu, Ling, Wang, Qiang, Hu, Hui-Hua, Xu, Hai-Peng, He, Zhi-Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356891/
https://www.ncbi.nlm.nih.gov/pubmed/27926500
http://dx.doi.org/10.18632/oncotarget.13787

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356891/
https://www.ncbi.nlm.nih.gov/pubmed/27926500
http://dx.doi.org/10.18632/oncotarget.13787

Ejemplares similares